// App-Quantinova.ai

3848 : Targeting hyaluronidase reduces stromal cell protection of chronic myeloid leukemia to imatinib therapy

Researchers

Presenter

  • Bryan Hostetler

Principal Investigators

  • Olga Uchakina

  • Robert McKallip

Medical Centers

  • Mercer University, Macon, GA.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Myelogenous Leukemia

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 44

  • Receptor for hyaluronic acid mediated motility

  • Hyaluronic acid

Drug/Treatment

  • Hyaluronic acid

  • Hyaluronidase

  • Imatinib

  • IkT001

  • L-Tyrosine

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved